NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Iovance Biotherapeutics Inc (NASDAQ: IOVA)

 
IOVA Technical Analysis
5
As on 9th Jun 2023 IOVA STOCK Price closed @ 7.89 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.79 & Strong Sell for SHORT-TERM with Stoploss of 16.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IOVASTOCK Price

Open 8.00 Change Price %
High 8.05 1 Day -0.11 -1.38
Low 7.72 1 Week -0.85 -9.73
Close 7.89 1 Month 2.53 47.20
Volume 3559700 1 Year -11.46 -59.22
52 Week High 20.16 | 52 Week Low 5.36
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
IOVA
Daily Charts
IOVA
Intraday Charts
Whats New @
Bazaartrend
IOVA
Free Analysis
 
IOVA Important Levels Intraday
RESISTANCE8.53
RESISTANCE8.32
RESISTANCE8.20
RESISTANCE8.07
SUPPORT7.71
SUPPORT7.58
SUPPORT7.46
SUPPORT7.25
 
IOVA Forecast May 2024
4th UP Forecast16.89
3rd UP Forecast14
2nd UP Forecast12.22
1st UP Forecast10.44
1st DOWN Forecast5.34
2nd DOWN Forecast3.56
3rd DOWN Forecast1.78
4th DOWN Forecast-1.11
 
IOVA Weekly Forecast
4th UP Forecast13.05
3rd UP Forecast11.40
2nd UP Forecast10.37
1st UP Forecast9.35
1st DOWN Forecast6.43
2nd DOWN Forecast5.41
3rd DOWN Forecast4.38
4th DOWN Forecast2.73
 
IOVA Forecast2024
4th UP Forecast37.41
3rd UP Forecast27.94
2nd UP Forecast22.09
1st UP Forecast16.24
1st DOWN Forecast-0.46
2nd DOWN Forecast-6.31
3rd DOWN Forecast-12.16
4th DOWN Forecast-21.63
 
 
IOVA Other Details
Segment EQ
Market Capital 3873086976.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IOVA Address
IOVA
 
IOVA Latest News
 
Your Comments and Response on Iovance Biotherapeutics Inc
 
IOVA Business Profile
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. Address: 999 Skyway Road, San Carlos, CA, United States, 94070
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service